More about

Pneumococcal Vaccines

News
December 11, 2024
1 min read
Save

Delayed methotrexate start improves pneumococcal vaccine response in rheumatoid arthritis

Delayed methotrexate start improves pneumococcal vaccine response in rheumatoid arthritis

WASHINGTON — Delaying methotrexate initiation for 1 month after pneumococcal vaccination improves humoral response in patients with rheumatoid arthritis, according to data presented at ACR Convergence 2024.

News
November 20, 2024
2 min watch
Save

VIDEO: Newest Red Book includes updates on RSV, pneumococcal vaccination

VIDEO: Newest <i>Red Book</i> includes updates on RSV, pneumococcal vaccination

NEW YORK — In this video from the Infectious Diseases in Children Symposium, David W. Kimberlin, MD, provides an overview of the topics that were added to the 2024-2027 Red Book published earlier this year.

News
October 23, 2024
2 min read
Save

CDC recommends 2nd COVID shot for some, lowering age for pneumococcal vaccination

CDC recommends 2nd COVID shot for some, lowering age for pneumococcal vaccination

A CDC advisory committee on Wednesday recommended that adults aged 65 years or older and anyone who is at least moderately immunocompromised receive a second dose of COVID-19 vaccine this season.

News
June 28, 2024
2 min read
Save

CDC recommends new COVID-19, pneumococcal vaccines

CDC recommends new COVID-19, pneumococcal vaccines

The CDC on Thursday recommended updated COVID-19 vaccines for the 2024-2025 respiratory season, and a newly approved 21-valent pneumococcal conjugate vaccine for adults.

News
November 18, 2023
2 min watch
Save

VIDEO: Adopting new pneumococcal vaccines into pediatric practice

VIDEO: Adopting new pneumococcal vaccines into pediatric practice

NEW YORK — In this video from the Infectious Diseases in Children Symposium, Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses the importance of pediatricians adopting new pneumococcal vaccines into practice to optimize patient coverage.

News
July 14, 2023
2 min read
Save

23-valent pneumococcal vaccine linked to necrosis, but risks do not outweigh benefits

23-valent pneumococcal vaccine linked to necrosis, but risks do not outweigh benefits

There have been some reports of necrosis at the injection site following receipt of the 23-valent pneumococcal vaccine, but the vaccine’s overall benefit-risk balance “remains favorable,” researchers wrote in JAMA Internal Medicine.

News
April 06, 2023
4 min read
Save

What physicians need to know to ensure simpler pneumococcal vaccine management

What physicians need to know to ensure simpler pneumococcal vaccine management

Over the last decade, there have been several updates to pneumococcal vaccinations in adolescents and adults, often leading to confusion among health care providers.

News
March 21, 2023
5 min read
Save

Pneumococcal vaccination: A public health priority

Pneumococcal vaccination: A public health priority

Over the past several years, adult pneumococcal vaccine recommendations have evolved based on the development of new vaccines.

News
January 06, 2023
1 min read
Save

FDA will review Pfizer’s 20-valent pneumococcal vaccine for children, infants

FDA will review Pfizer&rsquo;s 20-valent pneumococcal vaccine for children, infants

The FDA has accepted for priority review a supplemental biologics license application for Pfizer’s 20-valent pneumococcal conjugate vaccine for use in infants and children aged 6 weeks to 17 years, Pfizer announced.

News
December 30, 2022
2 min read
Save

Non-COVID-19 FDA news you may have missed in 2022

Non-COVID-19 FDA news you may have missed in 2022

There was plenty of FDA news this year not related to COVID-19.

View more